X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (27) 27
index medicus (26) 26
hematology (24) 24
aged (20) 20
middle aged (20) 20
male (19) 19
female (18) 18
oncology (17) 17
aged, 80 and over (15) 15
azacitidine (15) 15
adult (14) 14
cancer (12) 12
prognosis (12) 12
survival (12) 12
treatment outcome (12) 12
retrospective studies (11) 11
hematology, oncology and palliative medicine (10) 10
acute myeloid-leukemia (8) 8
classification (8) 8
leukemia, myeloid, acute - drug therapy (8) 8
myelodysplastic syndromes - mortality (8) 8
acute myeloid leukemia (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (7) 7
chemotherapy (7) 7
follow-up studies (7) 7
leukemia (7) 7
myelodysplastic syndromes - drug therapy (7) 7
scoring system (7) 7
antimetabolites, antineoplastic - therapeutic use (6) 6
azacitidine - therapeutic use (6) 6
impact (6) 6
leukemia, myeloid, acute - mortality (6) 6
myelodysplastic syndromes (6) 6
survival rate (6) 6
prospective studies (5) 5
risk (5) 5
young adult (5) 5
adolescent (4) 4
azacitidine - administration & dosage (4) 4
disease progression (4) 4
low-dose cytarabine (4) 4
mutations (4) 4
myelodysplastic syndrome (4) 4
myelodysplastic syndromes - genetics (4) 4
stem-cell transplantation (4) 4
survival analysis (4) 4
transplantation (4) 4
adults (3) 3
aml (3) 3
analysis (3) 3
antifungal agents - therapeutic use (3) 3
antimetabolites, antineoplastic - administration & dosage (3) 3
antimitotic agents (3) 3
antineoplastic agents (3) 3
aspergillosis (3) 3
combined modality therapy (3) 3
cytogenetics (3) 3
diagnosis (3) 3
elderly (3) 3
fever (3) 3
group-b (3) 3
health aspects (3) 3
immunology (3) 3
incidence (3) 3
intensive chemotherapy (3) 3
lenalidomide (3) 3
mds (3) 3
myelodysplastic syndromes - diagnosis (3) 3
myelodysplastic syndromes - therapy (3) 3
neutropenia (3) 3
older patients (3) 3
open-label (3) 3
outcome (3) 3
remission induction (3) 3
trial (3) 3
world-health-organization (3) 3
acute myelogenous leukemia (2) 2
age (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
biomarkers (2) 2
blood diseases (2) 2
bone marrow - pathology (2) 2
cancer-patients (2) 2
care and treatment (2) 2
chromosome aberrations (2) 2
chromosome deletion (2) 2
chromosomes, human, pair 5 - genetics (2) 2
comorbidities (2) 2
comorbidity (2) 2
complete remission (2) 2
conventional care regimens (2) 2
criteria (2) 2
cyclophosphamide (2) 2
cyclophosphamide - administration & dosage (2) 2
decitabine (2) 2
disease-free survival (2) 2
dosage and administration (2) 2
dosing schedules (2) 2
efficacy (2) 2
elderly-patients (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Transfusion, ISSN 0041-1132, 04/2015, Volume 55, Issue 4, pp. 875 - 879
Journal Article
European Journal of Haematology, ISSN 0902-4441, 12/2014, Volume 93, Issue 6, pp. 469 - 475
Journal Article
Journal Article
Clinical Lymphoma, Myeloma & Leukemia, ISSN 2152-2650, 2015, Volume 15, Issue 4, pp. 236 - 244
Journal Article
Journal Article
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 5241 - 5241
Abstract INTRODUCTION Karyotype is a key prognostic factor in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). Adverse karyotype (AK)... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 4363 - 4363
Abstract Several scores have been developed, such as the Sorror index, which allow to identify before transplant subgroups of patients with different risks of... 
Journal Article
Case reports in genetics, ISSN 2090-6544, 2014, Volume 2014, pp. 205318 - 3
Refractory anaemia with ring sideroblasts and marked thrombocytosis (RARS-T) is a provisional entity in the World Health Organization (WHO) classification. It... 
Case Report
Journal Article
Journal Article
International Journal of Molecular Sciences, ISSN 1661-6596, 04/2017, Volume 18, Issue 4, pp. 837 - 837
Journal Article
Journal Article
Clinical Lymphoma, Myeloma and Leukemia, ISSN 2152-2650, 07/2018, Volume 18, Issue 7, pp. 469 - 474.e1
Several prognostic factors such as intermediate karyotype, presence of 5% to 9% bone marrow blasts, and platelet count <50 × 10e /L are related to the... 
Score | Prognosis | Competing risk analysis | Acute myeloid leukemia | Predictive model | COMPETING RISK | CLASSIFICATION | ACUTE MYELOID-LEUKEMIA | AZACITIDINE | PROGNOSTIC MODEL | IMPACT | ONCOLOGY | COMORBIDITIES | LENALIDOMIDE | SCORING SYSTEM | HEMATOLOGY | STRATIFICATION
Journal Article